- Home
- DNA vs TRDA Comparison
DNA vs TRDA Comparison
Compare DNA & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- TRDA
- Stock Information
- Founded
- DNA 2008
- TRDA 2016
- Country
- DNA United States
- TRDA United States
- Employees
- DNA N/A
- TRDA N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- DNA Health Care
- TRDA Health Care
- Exchange
- DNA Nasdaq
- TRDA Nasdaq
- Market Cap
- DNA 562.1M
- TRDA 502.9M
- IPO Year
- DNA N/A
- TRDA 2021
- Fundamental
- Price
- DNA $6.46
- TRDA $10.82
- Analyst Decision
- DNA Sell
- TRDA Strong Buy
- Analyst Count
- DNA 5
- TRDA 3
- Target Price
- DNA $17.25
- TRDA $25.67
- AVG Volume (30 Days)
- DNA 2.0M
- TRDA 124.0K
- Earning Date
- DNA 05-08-2025
- TRDA 05-06-2025
- Dividend Yield
- DNA N/A
- TRDA N/A
- EPS Growth
- DNA N/A
- TRDA N/A
- EPS
- DNA N/A
- TRDA 1.68
- Revenue
- DNA $227,043,000.00
- TRDA $210,782,000.00
- Revenue This Year
- DNA N/A
- TRDA N/A
- Revenue Next Year
- DNA $19.36
- TRDA N/A
- P/E Ratio
- DNA N/A
- TRDA $6.68
- Revenue Growth
- DNA N/A
- TRDA 63.38
- 52 Week Low
- DNA $5.26
- TRDA $10.22
- 52 Week High
- DNA $48.00
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- DNA 28.50
- TRDA 35.70
- Support Level
- DNA $6.59
- TRDA $10.22
- Resistance Level
- DNA $7.34
- TRDA $11.04
- Average True Range (ATR)
- DNA 0.85
- TRDA 0.67
- MACD
- DNA -0.30
- TRDA 0.00
- Stochastic Oscillator
- DNA 2.63
- TRDA 16.67
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.